Stocks· May 02, 2026 at 03:46 PM

Mark Cuban Upgrades TrumpRx to 'A-' — 'They're Doing A Good Job Actually' Says Denting Big Insurance Conglomerates Is A 'Win'

NeutralMedium impact

AI summary

Mark Cuban isn't grading for style points—he's grading for impact. The billionaire co-founder of Cost Plus Drugs revisited TrumpRx and made clear what matters most: if it pressures the right players, it's working. From "B" To ‘A-' — Why The...

Affected symbols

GOOGL

Yahoo Finance · Read original

AI commentary is generated from public news feeds and is not investment advice.

Related coverage

StocksMedium impactNeutral20m

Here's Why I Wouldn't Touch Hyperliquid With a 10-Foot Pole

via Yahoo Finance

NVDA

StocksMedium impactNeutral31m

Tilray Brands to Expand Into the U.S. Marijuana Market? Why You Shouldn't Count on That Anytime Soon

via Yahoo Finance

NVDA

StocksMedium impactNeutral46m

If the Market Crashes, I'm Buying These 3 Stocks Before the Dust Settles

via Yahoo Finance

NVDA

StocksMedium impactNeutral53m

LinkedIn Co-Founder: AI Will Give Everyone Free Lawyers, Doctors and Teachers Within Years

via Yahoo Finance

NVDA